Menopause Supplements: What Actually Works and What Doesn’t
Dr. Karla Loken is a board-certified OB/GYN with over two decades of clinical experience and a distinguished career driving innovation in women's health across the pharmaceutical, diagnostics, and medical device industries. Through her consultancy, Loken & Associates, Dr. Loken provides medical affairs expertise and fractional Chief Medical Officer (CMO) services, helping early-stage companies bridge the gap between scientific innovation and industry application. She serves as Chief Medical Officer to MenoHealth. · 16 min read · Sep 2026
Medically reviewed by Karla F. Loken, DO, FACOOG on September 20, 2026

What menopause supplements actually work — and what doesn’t. An honest evidence review of black cohosh, soy, magnesium, vitamin D, and the rest.
A manufacturer can legally advertise a supplement 'helps maintain hormone health' or provides 'ovary support' without defining those terms or providing evidence of, well, anything. These quasi-scientific terms are very effective marketing. Who doesn't want to support their ovaries?
The supplement aisle aimed at women in midlife is a multi-billion-dollar industry. Most of the products on it are marketed with a confidence that doesn’t match the evidence behind them. This guide walks through what the actual research says about menopause supplements — which ones have credible evidence for which symptoms, which ones are sold harder than the data justifies, and how to think clearly about a category where the standards for quality, dosing, and safety are notably lower than for prescription medications.
If you’re trying to navigate this honestly without either dismissing supplements wholesale or believing the marketing copy, this is the article.
Key takeaways
Most menopause supplements have weaker evidence than their marketing suggests. A small subset has reasonable data for specific uses.
Black cohosh has mixed but mostly disappointing evidence for hot flushes; the Menopause Society’s 2023 nonhormone position statement does not recommend it.
Soy isoflavones have modest evidence for hot flushes in some women, particularly equol-producers, but the effect is smaller than hormone therapy.
Magnesium, vitamin D, and adequate calcium have specific, well-evidenced uses (sleep, bone health, fall prevention), though not as menopause-specific interventions.
The supplement industry is poorly regulated. Product quality, dosing accuracy, and content match-to-label vary substantially. Third-party testing matters.
Why menopause supplements are confusing
Three things make this category unusually hard to navigate.
First, the regulatory framework is weak. Unlike prescription medications, dietary supplements in the United States do not need to demonstrate efficacy before being marketed. The FDA’s role is reactive — it can pull products from the market for safety problems after the fact, but it does not vet products for whether they actually work. Manufacturers can make “structure-function” claims (“supports menopausal comfort”) without proving them, as long as they avoid disease claims.
Second, the clinical trial literature is uneven. Some menopause supplements have been studied in well-designed randomized trials. Many have been studied in small, short, low-quality trials whose results are then cited as evidence for products that don’t necessarily contain the same dose or formulation as the studied product. The phrase “clinically studied” in marketing rarely means what readers think it means.
Third, product quality varies dramatically. Independent testing has repeatedly found supplements that contain different amounts of active ingredient than the label claims, contaminants, or in some cases none of the named ingredient at all. The brand you buy matters more than in regulated medications.
The honest summary is that supplements are not a category where the standard advice (“ask your doctor”) gets you very far, because many clinicians have no specific training in supplement evidence. That puts more of the evaluation burden on you, which is the opposite of how the framing usually goes.
The supplements with the most evidence
Here’s an honest walk through what the data actually supports.
Black cohosh
Black cohosh (Actaea racemosa) is probably the most widely marketed supplement for hot flushes. The evidence for it is mixed, and the most rigorous synthesis is unfavorable.
A series of Cochrane reviews and well-designed randomized trials over the last two decades have generally found black cohosh either ineffective or marginally better than placebo for vasomotor symptoms. The mechanism is not well-established. The Menopause Society’s 2023 Nonhormone Therapy Position Statement does not recommend black cohosh as an evidence-supported treatment for vasomotor symptoms.
There’s a separate safety concern. Rare cases of liver toxicity have been reported in association with black cohosh, though causality is disputed and the risk appears low. Women with liver disease should avoid it.
If you’ve taken black cohosh and felt it helped, you’re not making it up — placebo response in vasomotor symptom trials is large, around 30-50%. But the trial evidence is not strong enough to recommend it broadly.
Soy isoflavones
I've heard people say, 'perimenopause and menopause are just natural parts of life, like women have dealt with it for all of humankind.' Just because something is natural doesn't mean we have to tolerate it.
Soy isoflavones (genistein, daidzein, and related compounds) are plant-based compounds with weak estrogen-like activity. They’ve been more rigorously studied than most menopause supplements, with mixed results.
Meta-analyses suggest soy isoflavones produce a modest reduction in hot flush frequency — typically around a 20-25% reduction beyond placebo — substantially less than hormone therapy. Effects appear stronger in women who are equol-producers (a minority of women have gut bacteria that convert daidzein to the more biologically active equol). Effects also appear stronger with higher doses (≥50 mg/day of isoflavones) and longer treatment durations (12+ weeks).
The Menopause Society’s 2023 position statement notes that isoflavones may have a small effect on VMS but does not include them in its recommended treatments. The signal is real but smaller than the marketing claims.
Soy is generally safe for most women, including most breast cancer survivors at typical dietary intake. High-dose isolated isoflavone supplements in breast cancer survivors is a more nuanced clinical question that warrants discussion with an oncology team.
Magnesium
Magnesium has reasonable evidence for sleep, less for direct menopausal symptoms.
Multiple small trials have shown that magnesium (typically 300-400 mg/day of magnesium glycinate, citrate, or related forms) modestly improves sleep quality, particularly in older adults with low dietary magnesium intake. The effect on hot flushes specifically is not well-established. There’s a small body of evidence that magnesium may help with menopause-related anxiety and mood, though it’s not robust.
Magnesium is also relevant for bone health and may help with constipation, which becomes more common in midlife. It’s generally safe at recommended doses; very high doses cause diarrhea and, rarely, more serious problems in women with kidney disease.
Our dedicated guide on magnesium for menopause walks through formulations and dosing in more detail.
Vitamin D
Vitamin D has clear evidence for bone health and fall prevention in postmenopausal women, and weaker evidence for mood and general well-being.
Adequate vitamin D status (typically defined as a 25-hydroxyvitamin D level above 30 ng/mL) is associated with reduced fracture risk in combination with calcium, particularly in older women. The benefit appears clearest in women who are deficient at baseline. Supplementing women who are already replete may not provide additional benefit.
For most women, 800-2000 IU per day of vitamin D3 is a reasonable dose, with higher doses sometimes used to correct documented deficiency. Levels can be checked with a simple blood test, which is more useful than guessing.
Vitamin D for hot flushes specifically does not have meaningful evidence. The bone and fall-prevention case is the real one.
Calcium
Calcium is essential for bone health in postmenopausal women, with the caveat that more is not better.
Current recommendations are 1,000-1,200 mg/day of total calcium intake (food + supplements combined) for women over 50. Most women can hit that with diet alone if they consume dairy, fortified plant milks, leafy greens, and certain fish. Women whose dietary intake is low may benefit from a supplement to reach the target.
What the evidence doesn’t support is extra-high-dose calcium supplementation. There’s some evidence that excessive calcium intake from supplements (but not food) may increase cardiovascular risk and kidney stone risk in some people. The goal is adequacy, not maximization.
Calcium is most often paired with vitamin D in supplement formulations because vitamin D is required for calcium absorption.
Omega-3 fatty acids (EPA/DHA)
We don't claim to have the final answer, but we think this represents an important step forward in empowering women and helping them live longer and live better.
Omega-3 fatty acids have well-established cardiovascular benefits and some evidence for mood support, though the menopause-specific signal is modest.
Small trials of omega-3 supplementation in menopausal women have shown inconsistent effects on hot flushes. The cardiovascular benefits, particularly in women with elevated triglycerides, are better-established and not menopause-specific. Omega-3s may have a modest effect on mood and depressive symptoms, with stronger evidence in women with diagnosable depression.
Reasonable doses are 1-2 grams per day of combined EPA + DHA from a third-party-tested source.
Probiotics
Specific probiotic strains have well-evidenced uses (recurrent yeast infections, certain GI conditions, recurrent UTIs in some women), but evidence for “probiotic supplements” as a general menopause intervention is weak. There is some emerging research on the gut-estrogen axis, but it doesn’t yet translate to specific product recommendations.
If you’re looking at probiotics for genitourinary symptoms specifically, our guide on is vaginal estrogen safe covers the more evidence-supported clinical option.
Supplements with weaker or no evidence
The following are widely marketed for menopausal symptoms with thin evidence.
Red clover. Like soy, contains isoflavones. The clinical trial evidence for menopausal symptoms is weaker than soy and largely unfavorable in meta-analyses. The Menopause Society’s 2023 statement does not recommend it.
Wild yam and “natural progesterone” creams. Wild yam cannot be converted to progesterone or estrogen in the body — the conversion happens only in a laboratory. Topical creams marketed as “natural progesterone” vary widely in actual hormone content; some contain no progesterone at all, others contain levels approaching prescription strength without the dosing precision or monitoring that prescription therapy involves. The category is confusing and poorly regulated.
Maca root. Some small trials suggest possible benefit for sexual function and mood, but the evidence base is small and limited by trial quality. Not unreasonable to try; not evidence-supported as a primary intervention.
DHEA (dehydroepiandrosterone). Oral DHEA for menopausal symptoms generally is not well-supported. Vaginal DHEA (prasterone) is FDA-approved as a prescription product for painful sex from genitourinary syndrome of menopause, and that’s a different clinical situation with stronger evidence.
Evening primrose oil. Studied for hot flushes in multiple small trials with generally negative results. Not recommended.
Sage, dong quai, ginseng, kava, hops, flaxseed, chasteberry. Each has small trial signals or theoretical mechanisms behind it, but none has consistent evidence sufficient to recommend broadly. Kava in particular has documented liver toxicity risk.
Multi-ingredient “menopause complex” supplements. These typically combine black cohosh, soy isoflavones, red clover, dong quai, and various adaptogens at sub-clinical doses. Even if individual ingredients had stronger evidence, the doses in combination products are often too low to match what’s been studied.
Cortisol-blocking and “hormone reset” supplements. Marketed heavily for menopause belly and stress. The pharmacology doesn’t support the marketing claims, and clinical trial evidence in menopausal women is essentially absent.
Safety considerations for supplements
The “natural” framing creates a false sense that supplements are inherently safe. They aren’t always.
Drug interactions. Many herbal supplements interact with prescription medications. St. John’s wort affects metabolism of dozens of drugs including hormonal contraceptives, antidepressants, and certain cancer therapies. Black cohosh may interact with tamoxifen. High-dose soy isoflavones in women with hormone-sensitive cancers is a question for oncology. Always disclose every supplement to your prescribing clinicians.
Liver toxicity. Several supplements marketed for menopause have rare but documented hepatotoxicity risk — including black cohosh, kava, and some weight-loss supplements. Women with baseline liver disease should be especially cautious.
Hormone-sensitive cancers. Women with histories of breast cancer or other estrogen-sensitive cancers should not use high-dose isoflavone supplements, “natural progesterone” creams, or other supplements with hormonal activity without explicit oncology guidance. Our guide on tamoxifen side effects covers the broader picture for cancer survivors.
Product quality. Look for third-party testing — USP, NSF, ConsumerLab.com, or Informed Choice certifications indicate the product has been independently verified to contain what the label says. This isn’t a guarantee of efficacy, but it’s the floor of basic quality assurance.
Doses matter. The dose used in a clinical trial may bear no relationship to the dose in the product on the shelf. If you’re considering a supplement based on a study you’ve read about, check the actual studied dose and formulation against what you’re buying.
What this means for you
If you’re navigating menopause symptoms, here’s a practical hierarchy.
First-line for moderate-to-severe symptoms: evidence-based medical treatments. For vasomotor symptoms, that means hormone therapy where appropriate, or evidence-supported non-hormonal prescription options including SSRIs, SNRIs, gabapentin, or fezolinetant. Our guides on medication for hot flushes and Veozah (fezolinetant) walk through those.
For bone and general health, regardless of symptoms: ensure adequate vitamin D and calcium intake (food first, supplement to fill the gap), consider omega-3s for cardiovascular support.
For sleep: magnesium is worth trying as a low-cost, low-risk option alongside addressing the underlying drivers of poor sleep. Our guide on menopause insomnia covers what works beyond supplements.
For mild vasomotor symptoms in women who can’t or won’t use prescription treatments: soy isoflavones at adequate doses (≥50 mg/day) for 12+ weeks have modest evidence and reasonable safety. Set realistic expectations — the effect is real but small.
Probably skip: multi-ingredient menopause complexes, cortisol blockers, “hormone reset” products, evening primrose oil for hot flushes, generic “metabolism boosters.” The cost is real and the evidence isn’t.
Always disclose every supplement to every clinician you see, especially before surgery and during cancer treatment. The interactions and risks are real even when the benefits are uncertain.
The general rule with this category: a small number of supplements have specific, evidence-supported uses. Most do not. The marketing is far ahead of the science, and the regulatory floor is low. Spending money on supplements with weak evidence is not just inefficient — it can delay engagement with the medical treatments that actually work for symptoms that are significantly affecting your life.
When to talk to your doctor
Reasonable triggers for a conversation include:
Considering hormone therapy or prescription non-hormonal treatment for vasomotor symptoms
A baseline assessment of bone health, vitamin D status, and fracture risk
Significant unexplained or new symptoms during the transition
Currently taking supplements and starting any new prescription medication
A history of estrogen-sensitive cancer, prior to taking any supplement with possible hormonal activity
Currently taking supplements and having any abnormal lab results, particularly liver enzymes
A clinician with menopause-specific training is better positioned to help you weigh the supplement question alongside the prescription options. Our guide on talking to your doctor about menopause covers how to prepare for that conversation.
Frequently asked questions
What’s the best supplement for menopause?
There’s no single best supplement because “menopause” isn’t one symptom. For bone health, vitamin D and calcium have the strongest evidence. For sleep, magnesium has modest evidence. For mild hot flushes when prescription options aren’t preferred, soy isoflavones have modest evidence. Multi-purpose menopause complexes generally lack rigorous evidence.
Does black cohosh work for hot flushes?
The evidence is mixed and mostly disappointing. Multiple Cochrane reviews and the Menopause Society’s 2023 Nonhormone Therapy Position Statement do not support black cohosh as an evidence-based treatment for vasomotor symptoms. Some women may feel benefit; the trial data suggests much of that may be placebo response.
Are menopause supplements safe?
Most are generally safe at recommended doses, but several caveats apply. The supplement industry is poorly regulated, product quality varies, several herbal supplements interact with prescription medications, and some have rare but documented liver toxicity risk. Women with histories of estrogen-sensitive cancer should be especially cautious with isoflavones and hormonal-activity products.
Is soy safe for breast cancer survivors?
Dietary soy intake (tofu, edamame, soy milk) is generally considered safe for most breast cancer survivors, with epidemiologic evidence suggesting it does not increase recurrence risk and may even be associated with lower risk. High-dose isolated isoflavone supplements are a more nuanced question that should be discussed with an oncology team.
Can I take menopause supplements while on HRT?
Most supplements don’t have known interactions with hormone therapy, but several do. St. John’s wort affects estrogen metabolism. Some supplements with weak hormonal activity (high-dose isoflavones, certain creams) may not be appropriate alongside hormone therapy. Always disclose supplements to your prescribing clinician.
What does “third-party tested” mean?
Third-party testing means an independent organization has verified that the product actually contains what the label says, in approximately the stated amount, without significant contamination. Common certifications include USP, NSF, ConsumerLab.com, and Informed Choice. This is a floor of quality assurance, not a guarantee of efficacy.
How long should I try a supplement before giving up on it?
For supplements with any plausible evidence base — soy isoflavones, magnesium for sleep — 8 to 12 weeks at an adequate dose is a reasonable trial. If you’ve seen no benefit after that, the supplement likely isn’t doing anything for you, and continued use is unlikely to change that.
Sources
The Menopause Society. The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society. Menopause. 2023;30(6):573-590.
The Menopause Society. The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.
Franco OH, Chowdhury R, Troup J, et al. Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis. JAMA. 2016;315(23):2554-2563.
National Institute for Health and Care Excellence. Menopause: identification and management (NG23). Updated November 2024.
Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine. 2015;175(4):531-539. SWAN cohort.
The Menopause Society. The 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society. Menopause. 2020;27(9):976-992.
Disclaimer
This article is for educational purposes and does not constitute medical advice. Always consult a qualified healthcare provider for guidance on your specific situation. Dietary supplements are regulated less rigorously than prescription medications; product quality and content vary across brands. Some supplements interact with prescription medications and may not be appropriate for women with certain medical conditions, including liver disease and hormone-sensitive cancers. Always disclose all supplements to your prescribing clinicians.




